Header cover image

Australian (ASX) Biotech Industry Analysis

UpdatedAug 26, 2026
DataAggregated Company Financials
Companies33
  • 7D8.2%
  • 3M63.2%
  • 1Y-17.8%
  • YTD0.9%

The Biotech industry is up 8.2% in the last week, with CSL up 3.6%. During this same period, the Telix Pharmaceuticals underperformed, falling 8.0%. In contrast, the industry has lost 18% in the last 12 months. Looking forward, earnings are forecast to grow by 42% annually.

Industry Valuation and Performance

Has the Australian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 27 Aug 2026AU$96.6bAU$23.7b-AU$4,097,137,519.1433.3x-23.6x4.1x
Sat, 25 Jul 2026AU$67.0bAU$23.6bAU$1.4b21.5x46.4x2.8x
Mon, 22 Jun 2026AU$67.7bAU$23.5bAU$1.4b22x47x2.9x
Wed, 20 May 2026AU$59.5bAU$23.2bAU$1.4b19.3x42.2x2.6x
Fri, 17 Apr 2026AU$78.2bAU$23.0bAU$1.4b24.1x56x3.4x
Sun, 15 Mar 2026AU$78.5bAU$23.6bAU$1.4b24.6x54.5x3.3x
Tue, 10 Feb 2026AU$97.8bAU$23.4bAU$3.8b20.4x25.7x4.2x
Thu, 08 Jan 2026AU$94.2bAU$24.4bAU$4.0b18.4x23.7x3.9x
Sat, 06 Dec 2025AU$101.8bAU$24.8bAU$4.1b19.6x25.1x4.1x
Mon, 03 Nov 2025AU$99.4bAU$25.1bAU$4.1b18.8x24.2x4x
Wed, 01 Oct 2025AU$107.9bAU$24.9bAU$4.1b21.1x26.5x4.3x
Fri, 29 Aug 2025AU$114.7bAU$25.1bAU$4.1b33.6x27.8x4.6x
Sun, 27 Jul 2025AU$143.8bAU$24.2bAU$3.8b46.3x37.6x5.9x
Tue, 24 Jun 2025AU$130.0bAU$24.9bAU$3.9b19.6x33x5.2x
Thu, 22 May 2025AU$132.9bAU$24.7bAU$3.9b20.7x34.1x5.4x
Sat, 19 Apr 2025AU$129.6bAU$24.9bAU$3.9b20.4x32.9x5.2x
Mon, 17 Mar 2025AU$135.8bAU$25.1bAU$4.0b21.4x34.1x5.4x
Wed, 12 Feb 2025AU$141.2bAU$25.2bAU$3.8b22.9x36.8x5.6x
Fri, 10 Jan 2025AU$154.3bAU$24.8bAU$3.7b24.4x41.6x6.2x
Sun, 08 Dec 2024AU$149.9bAU$24.1bAU$3.6b25.3x41.8x6.2x
Tue, 05 Nov 2024AU$151.2bAU$23.3bAU$3.5b26.9x43.7x6.5x
Thu, 03 Oct 2024AU$151.7bAU$22.3bAU$3.3b28.4x46.1x6.8x
Sat, 31 Aug 2024AU$159.8bAU$22.7bAU$3.4b30.1x46.9x7x
Mon, 29 Jul 2024AU$160.3bAU$22.5bAU$3.3b32.2x48.5x7.1x
Wed, 26 Jun 2024AU$153.4bAU$22.1bAU$3.2b32.2x47.2x6.9x
Fri, 24 May 2024AU$146.4bAU$22.1bAU$3.2b31.1x45.3x6.6x
Sun, 21 Apr 2024AU$138.9bAU$22.9bAU$3.4b28.9x41.3x6.1x
Tue, 19 Mar 2024AU$143.0bAU$22.4bAU$3.3b29.5x43.7x6.4x
Thu, 15 Feb 2024AU$142.7bAU$22.5bAU$3.3b30.6x43.1x6.3x
Sat, 13 Jan 2024AU$147.8bAU$20.5bAU$2.7b34.6x54.4x7.2x
Mon, 11 Dec 2023AU$135.8bAU$20.9bAU$2.8b33.8x49.1x6.5x
Wed, 08 Nov 2023AU$126.3bAU$21.4bAU$2.9b30.2x44.3x5.9x
Fri, 06 Oct 2023AU$126.1bAU$21.7bAU$2.9b29.3x43.6x5.8x
Sun, 03 Sep 2023AU$137.4bAU$21.3bAU$2.8b33.9x49.3x6.4x
Price to Earnings Ratio

49.3x


Total Market Cap: AU$137.4bTotal Earnings: AU$2.8bTotal Revenue: AU$21.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Biotech Industry Price to Earnings3Y Average 41x202420252026
Current Industry PE
  • Investors are pessimistic on the Australian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.4x is higher than the industry's current PS ratio of 4.1x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 3.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Australian Healthcare industry?

AU Market0.91%
Healthcare2.70%
Biotech8.17%
Biotech8.17%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CSL CSLAU$172.443.6%
+AU$2.9b
-20.1%PS3.8x
TTX TetratherixAU$6.6213.2%
+AU$40.8m
61.5%PS90.9x
PAR Paradigm BiopharmaceuticalsAU$0.2332.4%
+AU$32.7m
-22.4%PS15816.1x
PYC PYC TherapeuticsAU$2.170.9%
+AU$19.7m
67.6%PS103.8x
RAC Racura OncologyAU$2.203.8%
+AU$15.6m
76.0%PS125.6x

Latest News